Sen-Jam Pharmaceutical, a leader in developing innovative solutions to address inflammation at its root cause, proudly announces that its flagship asset, SJP-001, has received ethics approval for its ...

A significant gold target in Awalé's portfolio, marking a transformative achievement in 2024 with some of the highest-grade ...

Diversified Trust Co lowered its position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 19.2% during the fourth quarter, according to its most recent Form 13F filing with the ...

International Assets Investment Management LLC lowered its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 95.3 ...